申请人:Mochida Pharmaceutical Co. Ltd.
公开号:US05583227A1
公开(公告)日:1996-12-10
This invention relates to a novel compound which is useful as a drug in preventing and/or treating peptic ulcer-related diseases, to a production process thereof and to a pharmaceutical composition containing the same. Particularly, it provides a compound which has a specified substituted alkynylpyrazine nucleus or a specified substituted alkynylquinoxaline nucleus, represented by the following formula (I) ##STR1## wherein A is represented by the following formula (II) or (III) ##STR2## and R.sup.1 is represented by the following formula (IV), ##STR3## and the salts thereof, a production process thereof and a pharmaceutical composition containing the same. The inventive compound is useful as a drug in preventing and/or treating peptic ulcer-related diseases.
这项发明涉及一种新型化合物,可用作预防和/或治疗消化性溃疡相关疾病的药物,以及其生产工艺和含有该化合物的药物组合物。特别地,它提供了一种具有特定取代炔基吡嗪核或特定取代炔基喹喔啉核的化合物,由以下式(I)表示:##STR1## 其中A由以下式(II)或(III)表示:##STR2## 而R.sup.1由以下式(IV)表示:##STR3## 及其盐,其生产工艺和含有该化合物的药物组合物。这种创新的化合物可用作预防和/或治疗消化性溃疡相关疾病的药物。